Location: Home > Pharma China Web Edition
  • search
  • go
  • Editor's Picks
  • 2/25/2021CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
  • 2/25/2021Biosecurity Law of the P.R.C. - Full Text Unofficial Translation
  • 2/25/2021PharmaNJ's China NMPA Approved Tracker: Jan 2021
  • 2/23/2021PharmaDJ's China Licensing Deals Tracker: Jan 2021
  • 2/22/2021The Race to the Top: Does China Have What It Takes?
  • 2/22/2021How Foreign Companies Can Break Into China's Biosimilar Market and Rel...
  • 2/9/2021NLR: China's Patent Office Releases Draft Measures for Patent Linkage ...
  • 2/9/2021SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...
  • 2/8/2021Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
  • 2/4/2021Changes To Biotech And Chemical Patent Examination - Recent Amendments...
  • 2/3/2021AJMC: China Pulls Out Stops for Biosimilar Development
  • 1/28/2021The 2020 China Report of the Lancet Countdown on Health and Climate Ch...
  • 1/28/2021Chofn IP: Recordation of Patent License Agreement In China
  • 1/28/2021Chofn IP: Patent Protection of Multinational Joint Invention in China
  • 1/28/2021Revised Chinese Patent Examination Guidelines Took Effect from Januar...
  • 1/21/2021Lesson from China's National Negotiation of Drug Prices in 2020
  • 1/21/2021Chinese Civil Code Introduces Punitive Damages Against IP Infringement
  • 1/21/2021New Judicial Interpretation in China Strengthens Protection of Trade S...
  • 1/21/2021Coronavirus in China: 2021 Outlook Brightens for Health Care Operators...
  • 1/21/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
  • 1/19/2021BioWorld: Luye's Schizophrenia Drug Approval in China Challenges J&J's...
  • 1/19/2021PL: Facing Aggressive Price Cuts at Home, Chinese Biotechs Must Go Glo...
  • 1/18/2021Top JPMorgan Banker Sees Steady Supply of Chinese Health Care IPOs, Ev...
  • 1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...
  • 1/14/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
  • 1/8/2021S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...
  • 1/8/2021SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...
  • 1/7/2021Economic Burden and Health Care Access for Patients with IBD in China:...
  • 12/29/2020Merck, Bristol Myers, AstraZeneca and Roche Lose Bid to Expand PD-1/L1...
  • 12/23/2020PharmaDJ: PSR Filing System Landed
  • Page:1/5 Total number of articles:124: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group